Gastrointestinal Pathogen Panel

  • Qualitative multiplexed nucleic acid-based in vitro diagnostic test 
  • Simultaneously detect and identify 17 gastrointestinal pathogens including viral, bacterial, and parasitic organisms that cause diarrhea in a single test
Gastrointestinal Pathogen Panel

The BioCode® Gastrointestinal Pathogen Panel* utilizes proven Barcoded Magnetic Bead technology to detect specific gastrointestinal microbial nucleic acid from individuals exhibiting signs and symptoms of infections. The BioCode® Gastrointestinal Pathogen Panel Assay is a flexible, cost effective, comprehensive molecular test that detects and identifies the 17 most common causative pathogens in raw stool specimens or stool in Cary-Blair medium from symptomatic patients.

The Applied BioCode® Gastrointestinal Pathogen Panel with MDx-3000 system can identify the following:

Pathogens Detected
  • Campylobacter (C. jejuni/C. coli)
  • Clostridium difficile toxins A and B
  • E. coli O157
  • Enterotoxigenic E. coli LT/ST (ETEC)
  • Enteroaggregative E. coli (EAEC)
  • Salmonella spp.
  • Shiga-like toxin producing E. coli stx1/stx2 (STEC)
  • Shigella/Enteroinvasive E. coli (EIEC)
  • Vibrio spp.
  • Vibrio parahemolyticus
  • Yersinia enterocolitica
  • Adenovirus 40/41
  • Norovirus GI/GII
  • Rotavirus A
  • Cryptosporidium (C. hominis/ C. parvum)
  • Entamoeba histolytica
  • Giardia lamblia
Internal Control
  • MS2

Features and Benefits of the BioCode® Gastrointestinal Pathogen Panel


  • Delivers 188 patient samples in an 8-hour shift


  • Data Masking option enables select target reporting based on clinician’s order


  • Detect and identify 17 microbial pathogens
  • Parallel testing with other FDA-cleared BioCode® assays

BioCode® Gastrointestinal Pathogen Panel

Gastrointestinal Pathogen Panel

*The BioCode® Gastrointestinal Pathogen Panel is US FDA 510(k) cleared in the US and CE Mark in Europe.